Libin Abraham
Impact in
- Virology top 2%
- HIV Research and Treatment
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Virology 10
- HIV Research and Treatment 10
- Immunology 12
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 4
- Co-authors
- Oliver Till Fackler (9 shared papers)Xiaoyu Pan (5 shared papers)Bettina Stolp (2 shared papers)Michael R. Gold (7 shared papers)Erez Raz (1 shared paper)Daniel Coombs (3 shared papers)Sebastian Hannemann (1 shared paper)Robert Grosse (1 shared paper)
- Journals
- Retrovirology (2 papers)Proceedings of the National Academy of Sciences (2 papers)Nature Communications (2 papers)mBio (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)
- Partner nations
- CanadaGermanyUnited States
In The Last Decade
Libin Abraham
23 papers receiving 882 citations
Libin Abraham's Hit Papers
Peers
Comparison fields: 5 of 86
- Virology 293
- Immunology 325
- Immunology and Allergy 46
- Infectious Diseases 115
- Oncology 142
Countries citing papers authored by Libin Abraham
This map shows the geographic impact of Libin Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libin Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libin Abraham more than expected).
Fields of papers citing papers by Libin Abraham
This network shows the impact of papers produced by Libin Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libin Abraham. The network helps show where Libin Abraham may publish in the future.
Co-authors
The 25 scholars most cited alongside Libin Abraham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity Hit paper breakdown → | 2023 | 130 |
| 2 | 2009 | 116 | |
| 3 | 2012 | 76 | |
| 4 | 2015 | 68 | |
| 5 | 2019 | 66 | |
| 6 | 2020 | 64 | |
| 7 | 2011 | 55 | |
| 8 | 2019 | 52 | |
| 9 | 2010 | 48 | |
| 10 | 2017 | 47 | |
| 11 | 2016 | 34 | |
| 12 | 2015 | 27 | |
| 13 | 2012 | 27 | |
| 14 | 2017 | 21 | |
| 15 | 2017 | 16 | |
| 16 | 2016 | 14 | |
| 17 | 2021 | 10 | |
| 18 | 2022 | 9 | |
| 19 | 2021 | 5 | |
| 20 | HIV-1 Nef | 2012 | 5 |
About Libin Abraham
Libin Abraham is a scholar working on Virology, Immunology, Oncology, Immunology and Allergy and Complementary and alternative medicine, having authored 26 papers that have together received 894 indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cell Adhesion Molecules Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Virology (293 citations), Immunology (325 citations), Immunology and Allergy (46 citations), Infectious Diseases (115 citations) and Oncology (142 citations). Libin Abraham has collaborated with scholars based in Canada, Germany and United States. Frequent co-authors include Oliver Till Fackler, Xiaoyu Pan, Bettina Stolp, Michael R. Gold, Erez Raz, Daniel Coombs, Sebastian Hannemann, Robert Grosse, Michal Reichman‐Fried and Kate Choi. Their work appears in journals such as Retrovirology, Proceedings of the National Academy of Sciences, Nature Communications, mBio and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.